Orchid Pharma submits monitoring agency report

14 Aug 2023 Evaluate
Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements Regulations, 2018, Orchid Pharma has informed that it enclosed Monitoring Agency Report issued by Care Ratings, Monitoring Agency, for the quarter ended June 30, 2023 in respect of utilization of proceeds raised through Qualified Institutional Placement.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

668.40 -0.60 (-0.09%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×